MOLECULE HOLDINGS Market Cap ($57.16K)
Market Cap & Net Worth: MOLECULE HOLDINGS (ERV2)
MOLECULE HOLDINGS market cap. MOLECULE HOLDINGS (F:ERV2) has a market capitalization of $57.16K (€48.89K) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #31652 globally and #2832 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MOLECULE HOLDINGS's stock price €0.00 by its total outstanding shares 97781904 (97.78 Million). Also see ERV2 cash flow metrics for how efficiently the company converts equity into cash flow.
MOLECULE HOLDINGS Market Cap History (2015–2026)
MOLECULE HOLDINGS market cap history from 2015 to 2026. Data shows change from $114.32K to $57.16K (-24.43% CAGR). Check latest MOLECULE HOLDINGS stock price today for real-time trading data and today's change.
MOLECULE HOLDINGS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MOLECULE HOLDINGS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore MOLECULE HOLDINGS (ERV2) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.41x
MOLECULE HOLDINGS's market cap is 0.41 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $3.94 Million | $455.26K | -$4.23 Million | 8.66x | N/A |
| 2022 | $800.22K | $1.97 Million | -$4.54 Million | 0.41x | N/A |
Competitor Companies of ERV2 by Market Capitalization
Companies near MOLECULE HOLDINGS in the global market cap rankings as of November 3, 2026. Also see MOLECULE HOLDINGS (ERV2) total assets for a full breakdown of the balance sheet.
Key companies related to MOLECULE HOLDINGS by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #516 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #591 globally with a market cap of $45.45 Billion USD ( CN¥310.59 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #516 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.55 |
| #591 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.45 Billion | CN¥48.69 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of MOLECULE HOLDINGS (2015–2026)
Market capitalization of MOLECULE HOLDINGS from 2015 to today. Between 2015 and today, MOLECULE HOLDINGS's market cap moved from $114.32K to $ 57.16K, with a yearly change of -24.43%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €57.16K | 0.00% |
| 2025 | €57.16K | 0.00% |
| 2024 | €57.16K | 0.00% |
| 2023 | €57.16K | -92.86% |
| 2022 | €800.22K | -79.71% |
| 2021 | €3.94 Million | -36.11% |
| 2020 | €6.17 Million | +620.00% |
| 2019 | €857.38K | -58.33% |
| 2018 | €2.06 Million | -14.29% |
| 2017 | €2.40 Million | -47.50% |
| 2016 | €4.57 Million | +3900.00% |
| 2015 | €114.32K | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of MOLECULE HOLDINGS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $57.16K USD |
| MoneyControl | $57.16K USD |
| MarketWatch | $57.16K USD |
| marketcap.company | $57.16K USD |
| Reuters | $57.16K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MOLECULE HOLDINGS
Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages in Canada. It also offers cannabis extracts, beverages, edibles, and topical products directly to provincial retailers. The company offers its beverage products under the PHRESH, KLÕN, EMBODY, and CANAJO brands. Molecule Holdings Inc. is based in Lansdowne, Canada.